News | February 02, 2023
Jubilant Ingrevia posts Q3FY23 consolidated PAT at Rs. 91.53 Cr
The company has reported total income of Rs. 1165.31 crores during the period ended December 31, 2022
The company has reported total income of Rs. 1165.31 crores during the period ended December 31, 2022
Most of the new growth Capex investments are happening on the Specialty Chemicals and Nutrition side
The rating withdrawal is based on the company’s request and in line with CRISIL Rating’s policy on withdrawal of ratings.
Subscribe To Our Newsletter & Stay Updated
